APA

Kote-Jarai Z., Leongamornlert D., Saunders E., Tymrakiewicz M., Castro E., Mahmud N., Guy M., Edwards S., O'Brien L., Sawyer E., Hall A., Wilkinson R., Dadaev T., Goh C., Easton D., Goldgar D. & Eeles R. (20111121). BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients. : British journal of cancer.

Chicago

Kote-Jarai Z, Leongamornlert D, Saunders E, Tymrakiewicz M, Castro E, Mahmud N, Guy M, Edwards S, O'Brien L, Sawyer E, Hall A, Wilkinson R, Dadaev T, Goh C, Easton D, Goldgar D and Eeles R. 20111121. BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients. : British journal of cancer.

Harvard

Kote-Jarai Z., Leongamornlert D., Saunders E., Tymrakiewicz M., Castro E., Mahmud N., Guy M., Edwards S., O'Brien L., Sawyer E., Hall A., Wilkinson R., Dadaev T., Goh C., Easton D., Goldgar D. and Eeles R. (20111121). BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients. : British journal of cancer.

MLA

Kote-Jarai Z, Leongamornlert D, Saunders E, Tymrakiewicz M, Castro E, Mahmud N, Guy M, Edwards S, O'Brien L, Sawyer E, Hall A, Wilkinson R, Dadaev T, Goh C, Easton D, Goldgar D and Eeles R. BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients. : British journal of cancer. 20111121.